Some studies have shown that polycystic ovary syndrome, which affects 6–8% of women of reproductive age, and insulin insensitivity (or resistance), which are both components of metabolic syndrome, may play a role in the pathogenesis of endometrial cancer, perhaps through hormonal disruption, which causes higher androgen and estrogen levels and lower progesterone levels [10]. This evidence concerns the gene INS and endometrial cancer.